IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 48 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $19,688 | -6.2% | 56,250 | 0.0% | 1.50% | +5.5% |
| Q3 2022 | $21,000 | -19.2% | 56,250 | 0.0% | 1.42% | -26.4% |
| Q2 2022 | $26,000 | -7.1% | 56,250 | 0.0% | 1.94% | +1.1% |
| Q1 2022 | $28,000 | -12.5% | 56,250 | 0.0% | 1.91% | +3.4% |
| Q4 2021 | $32,000 | -44.8% | 56,250 | 0.0% | 1.85% | -23.2% |
| Q3 2021 | $58,000 | -14.7% | 56,250 | 0.0% | 2.41% | +957.0% |
| Q2 2021 | $68,000 | -6.8% | 56,250 | 0.0% | 0.23% | +533.3% |
| Q1 2021 | $73,000 | -64.6% | 56,250 | 0.0% | 0.04% | -70.2% |
| Q4 2020 | $206,000 | – | 56,250 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 56,250 | $206,000 | 0.12% |
| Baker Brothers Advisors | 4,608,786 | $16,914,000 | 0.06% |
| Artal Group S.A. | 500,000 | $1,835,000 | 0.04% |
| HOLLENCREST CAPITAL MANAGEMENT | 90,000 | $331,000 | 0.04% |
| Spotlight Asset Group, Inc. | 21,500 | $79,000 | 0.03% |
| DCF Advisers, LLC | 18,755 | $69,000 | 0.03% |
| 683 Capital Management, LLC | 88,470 | $325,000 | 0.02% |
| Palo Alto Investors LP | 77,044 | $283,000 | 0.02% |
| Alpine Global Management, LLC | 13,966 | $51,000 | 0.01% |
| TCI Wealth Advisors, Inc. | 4,000 | $15,000 | 0.01% |